424 related articles for article (PubMed ID: 29074854)
1. Gag P2/NC and pol genetic diversity, polymorphism, and drug resistance mutations in HIV-1 CRF02_AG- and non-CRF02_AG-infected patients in Yaoundé, Cameroon.
Teto G; Tagny CT; Mbanya D; Fonsah JY; Fokam J; Nchindap E; Kenmogne L; Njamnshi AK; Kanmogne GD
Sci Rep; 2017 Oct; 7(1):14136. PubMed ID: 29074854
[TBL] [Abstract][Full Text] [Related]
2. Identification of new, emerging HIV-1 unique recombinant forms and drug resistant viruses circulating in Cameroon.
Ragupathy V; Zhao J; Wood O; Tang S; Lee S; Nyambi P; Hewlett I
Virol J; 2011 Apr; 8():185. PubMed ID: 21513545
[TBL] [Abstract][Full Text] [Related]
3. Characterization of drug resistance mutations in naïve and ART-treated patients infected with HIV-1 in Yaounde, Cameroon.
Ceccarelli L; Salpini R; Moudourou S; Cento V; Santoro MM; Fokam J; Takou D; Nanfack A; Dori L; Torimiro J; Sarmati L; Andreoni M; Perno CF; Colizzi V; Cappelli G
J Med Virol; 2012 May; 84(5):721-7. PubMed ID: 22431019
[TBL] [Abstract][Full Text] [Related]
4. High resistance to reverse transcriptase inhibitors among persons infected with human immunodeficiency virus type 1 subtype circulating recombinant form 02_AG in Ghana and on antiretroviral therapy.
Deletsu SD; Maina EK; Quaye O; Ampofo WK; Awandare GA; Bonney EY
Medicine (Baltimore); 2020 Feb; 99(7):e18777. PubMed ID: 32049783
[TBL] [Abstract][Full Text] [Related]
5. Pre-treatment drug resistance and HIV-1 genetic diversity in the rural and urban settings of Northwest-Cameroon.
Fokam J; Takou D; Teto G; Nforbih SE; Kome OP; Santoro MM; Ngoufack ES; Eyongetah M; Palmer D; Fokunang ET; Fokunang CN; Colizzi V; Perno CF; Ndjolo A
PLoS One; 2020; 15(7):e0235958. PubMed ID: 32692778
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of human immunodeficiency virus type 1 (HIV-1) and HIV-2 in Yaounde, Cameroon: evidence of major drug resistance mutations in newly diagnosed patients infected with subtypes other than subtype B.
Ndembi N; Abraha A; Pilch H; Ichimura H; Mbanya D; Kaptue L; Salata R; Arts EJ
J Clin Microbiol; 2008 Jan; 46(1):177-84. PubMed ID: 17855574
[TBL] [Abstract][Full Text] [Related]
7. Mutations in HIV-1 gag and pol compensate for the loss of viral fitness caused by a highly mutated protease.
Kozísek M; Henke S; Sasková KG; Jacobs GB; Schuch A; Buchholz B; Müller V; Kräusslich HG; Rezácová P; Konvalinka J; Bodem J
Antimicrob Agents Chemother; 2012 Aug; 56(8):4320-30. PubMed ID: 22644035
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 drug resistance testing is essential for heavily-treated patients switching from first- to second-line regimens in resource-limited settings: evidence from routine clinical practice in Cameroon.
Takou D; Fokam J; Teto G; Santoro MM; Ceccherini-Silberstein F; Nanfack AJ; Sosso SM; Dambaya B; Salpini R; Billong SC; Gori C; Fokunang CN; Cappelli G; Colizzi V; Perno CF; Ndjolo A
BMC Infect Dis; 2019 Mar; 19(1):246. PubMed ID: 30871487
[TBL] [Abstract][Full Text] [Related]
9. Monitoring HIV-1 Group M Subtypes in Yaoundé, Cameroon Reveals Broad Genetic Diversity and a Novel CRF02_AG/F2 Infection.
Courtney CR; Agyingi L; Fokou A; Christie S; Asaah B; Meli J; Ngai J; Hewlett I; Nyambi PN
AIDS Res Hum Retroviruses; 2016 Apr; 32(4):381-5. PubMed ID: 26681241
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of drug resistance among B and the most prevalent non-B HIV type 1 subtypes (C, F, and CRF02_AG) in Italy.
Santoro MM; Alteri C; Ronga L; Flandre P; Fabeni L; Mercurio F; D'Arrigo R; Gori C; Palamara G; Bertoli A; Forbici F; Salpini R; Boumis E; Tozzi V; Visco-Comandini U; Zaccarelli M; Van Houtte M; Pattery T; Narciso P; Antinori A; Ceccherini-Silberstein F; Perno CF
AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1285-93. PubMed ID: 22417570
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the diversity of the HIV-1 pol gene and drug resistance associated changes among drug-naïve patients in Burkina Faso.
Tebit DM; Sangaré L; Tiba F; Saydou Y; Makamtse A; Somlare H; Bado G; Kouldiaty BG; Zabsonre I; Yameogo SL; Sathiandee K; Drabo JY; Kräusslich HG
J Med Virol; 2009 Oct; 81(10):1691-701. PubMed ID: 19697403
[TBL] [Abstract][Full Text] [Related]
12. V118I substitution in the reverse transcriptase gene of HIV type 1 CRF02_AG strains infecting drug-naive individuals in Cameroon.
Konings FA; Nyambi PN
AIDS Res Hum Retroviruses; 2004 Jun; 20(6):673-8. PubMed ID: 15242545
[TBL] [Abstract][Full Text] [Related]
13. Dynamic HIV-1 genetic recombination and genotypic drug resistance among treatment-experienced adults in northern Ghana.
Nii-Trebi NI; Brandful JAM; Ibe S; Sugiura W; Barnor JS; Bampoh PO; Yamaoka S; Matano T; Yoshimura K; Ishikawa K; Ampofo WK
J Med Microbiol; 2017 Nov; 66(11):1663-1672. PubMed ID: 29068286
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 drug resistance and genetic diversity in people with HIV-1 in Cape Verde.
Gonçalves P; Barreto J; Santos M; Leal S; Marcelino J; Abecasis A; Palladino C; Taveira N
AIDS; 2024 Jul; 38(8):1101-1110. PubMed ID: 38349224
[TBL] [Abstract][Full Text] [Related]
15. Detection of Gag C-terminal mutations among HIV-1 non-B subtypes in a subset of Cameroonian patients.
Teto G; Nka AD; Fokam J; Bouba Y; Takou D; Fabeni L; Carioti L; Armenia D; Semengue ENJ; Dambaya B; Sosso SM; Colizzi V; Perno CF; Ceccherini-Silberstein F; Santoro MM; Ndjolo A
Sci Rep; 2022 Jan; 12(1):1374. PubMed ID: 35082353
[TBL] [Abstract][Full Text] [Related]
16. Impact of gag genetic determinants on virological outcome to boosted lopinavir-containing regimen in HIV-2-infected patients.
Larrouy L; Vivot A; Charpentier C; Bénard A; Visseaux B; Damond F; Matheron S; Chene G; Brun-Vezinet F; Descamps D;
AIDS; 2013 Jan; 27(1):69-80. PubMed ID: 23018441
[TBL] [Abstract][Full Text] [Related]
17. Human Immunodeficiency Virus Type-1 Genetic Diversity and Drugs Resistance Mutations among People Living with HIV in Karachi, Pakistan.
Rashid A; Kang L; Yi F; Chu Q; Shah SA; Mahmood SF; Getaneh Y; Wei M; Chang S; Abidi SH; Shao Y
Viruses; 2024 Jun; 16(6):. PubMed ID: 38932254
[TBL] [Abstract][Full Text] [Related]
18. Genetic diversity and drug resistance of HIV-1 among infected pregnant women newly diagnosed in Luanda, Angola.
Sebastião CS; Neto Z; de Jesus CS; Mirandela M; Jandondo D; Couto-Fernandez JC; Tanuri A; Morais J; Brito M
PLoS One; 2019; 14(11):e0225251. PubMed ID: 31770425
[TBL] [Abstract][Full Text] [Related]
19. Genetic diversity and antiretroviral resistance-associated mutation profile of treated and naive HIV-1 infected patients from the Northwest and Southwest regions of Cameroon.
Meriki HD; Tufon KA; Anong DN; Atanga PN; Anyangwe IA; Cho-Ngwa F; Nkuo-Akenji T
PLoS One; 2019; 14(11):e0225575. PubMed ID: 31751428
[TBL] [Abstract][Full Text] [Related]
20. Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain.
de Mulder M; Yebra G; Martín L; Prieto L; Mellado MJ; Rojo P; Muñoz-Fernández MÁ; Jiménez de Ory S; Ramos JT; Holguín A;
J Antimicrob Chemother; 2011 Oct; 66(10):2362-71. PubMed ID: 21810838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
